日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Probabilistic human health risk assessment of trace metal exposure in Australian homes: insights from a legacy industrial region

澳大利亚家庭微量金属暴露的概率性人体健康风险评估:来自传统工业区的启示

Ibañez-Del Rivero, Carlos; Aelion, C Marjorie; Taylor, Mark Patrick

Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial

使用阿普米司特治疗早期少关节型银屑病关节炎:FOREMOST随机对照试验第16周的主要结果

Gossec, Laure; Coates, Laura C; Gladman, Dafna D; Aelion, Jacob A; Vasandani, Jitendra; Pinter, Andreas; Merola, Joseph F; Kavanaugh, Arthur; Reddy, Jyotsna; Wang, Rebecca; Brunori, Michele; Klyachkin, Yuri; Deignan, Cynthia; Mease, Philip J

Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial

在类风湿性关节炎患者中,乌帕替尼单药治疗与甲氨蝶呤单药治疗的疗效和安全性比较:SELECT-EARLY随机对照试验5年随访结果

van Vollenhoven, Ronald; Strand, Vibeke; Takeuchi, Tsutomu; Chávez, Nilmo; Walter, Pablo Mannucci; Singhal, Atul; Swierkot, Jerzy; Khan, Nasser; Bu, Xianwei; Li, Yihan; Penn, Sara K; Camp, Heidi S; Aelion, Jacob

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial

Risankizumab治疗活动性银屑病关节炎的疗效和安全性:KEEPsAKE 2随机临床试验的100周结果

Östör, Andrew; Van den Bosch, Filip; Papp, Kim; Asnal, Cecilia; Blanco, Ricardo; Aelion, Jacob; Carter, Kyle; Stakias, Vassilis; Lippe, Ralph; Drogaris, Leonidas; Soliman, Ahmed M; Chen, Michael M; Padilla, Byron; Kivitz, Alan

Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study

利沙珠单抗治疗活动性银屑病关节炎的疗效和安全性:KEEPsAKE 2 研究的 52 周结果

Östör, Andrew; Van den Bosch, Filip; Papp, Kim; Asnal, Cecilia; Blanco, Ricardo; Aelion, Jacob; Lu, Wenjing; Wang, Zailong; Soliman, Ahmed M; Eldred, Ann; Padilla, Byron; Kivitz, Alan

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial

利沙珠单抗治疗活动性银屑病关节炎的疗效和安全性:来自随机、双盲、3期KEEPsAKE 2试验的24周结果

Östör, Andrew; Van den Bosch, Filip; Papp, Kim; Asnal, Cecilia; Blanco, Ricardo; Aelion, Jacob; Alperovich, Gabriela; Lu, Wenjing; Wang, Zailong; Soliman, Ahmed M; Eldred, Ann; Barcomb, Lisa; Kivitz, Alan

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

阿普米司特单药治疗对未接受过生物制剂治疗的银屑病关节炎患者的早期和持续疗效:一项 IIIB 期随机对照试验 (ACTIVE)

Nash, Peter; Ohson, Kamal; Walsh, Jessica; Delev, Nikolay; Nguyen, Dianne; Teng, Lichen; Gómez-Reino, Juan J; Aelion, Jacob A

ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate: A Randomized, Double-Blind Study

ABT-122,一种靶向肿瘤坏死因子和白细胞介素-17A的双特异性双可变区免疫球蛋白,用于治疗对甲氨蝶呤反应不足的类风湿性关节炎患者:一项随机、双盲研究

Genovese, Mark C; Weinblatt, Michael E; Aelion, Jacob A; Mansikka, Heikki T; Peloso, Paul M; Chen, Kun; Li, Yihan; Othman, Ahmed A; Khatri, Amit; Khan, Nasser S; Padley, Robert J

Activated ovarian endothelial cells promote early follicular development and survival

活化的卵巢内皮细胞促进早期卵泡发育和存活

Alon Kedem, Anate Aelion-Brauer, Peipei Guo, Duancheng Wen, Bi-Sen Ding, Raphael Lis, Du Cheng, Vladislav M Sandler, Shahin Rafii, Zev Rosenwaks

Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study

司库奇尤单抗治疗抗TNFα疗法后活动性类风湿关节炎:一项随机、双盲、安慰剂对照的3期研究

Tahir, Hasan; Deodhar, Atul; Genovese, Mark; Takeuchi, Tsutomu; Aelion, Jacob; Van den Bosch, Filip; Haemmerle, Sibylle; Richards, Hanno B